MGNX logo

MGNXMacrogenics Inc

$3.91
$0.34
(8.00%)
Today
Closed $3.91
$0.0192
(0.49%)
After Hours
Updated: 07:56 PM EDT
Reported EarningsMay 13
Mkt Cap$248.53M
Vol560,054.00
News
all
press releases
Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance
Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.
Zacks
News Placeholder
More News
News Placeholder
MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of -1.75% and +12.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Wall Street’s Risk-On Frenzy Returns
Among the session’s standout movers were Quantum Computing, which blasted through more than $1 billion in trading volume after reporting massive revenue growth and expanding its quantum-photonics footprint. Meanwhile, speculative traders also rotated heavily into AI-linked names including Dreamland Limited and media turnaround story BuzzFeed, both of which are holding onto substantial gains throughout the session. $TGNT, $QUBT, $BZFD, $TDIC, $HTCO, $MGNX, $CNCK, $VSTS
24-7 Market News
News Placeholder
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising guidance. Other gainers include Buzzfeed, MacroGenics, & SI-Bone.read more...
Benzinga
News Placeholder
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -32.48% and +1.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of +1.04% and +2.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
MacroGenics (MGNX) to Release Quarterly Earnings on Tuesday
MacroGenics (NASDAQ:MGNX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-macrogenics-inc-stock...
MarketBeat
News Placeholder
Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know
MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
News Placeholder
MacroGenics Expands Zynyz Royalty Deal With Sagard
(RTTNews) - MacroGenics, Inc. (MGNX) on Monday said it has entered into an expanded royalty purchase agreement with Sagard Healthcare Partners, under which it will receive funding in exchange for a...
Nasdaq News: Markets
News Placeholder
MacroGenics, Inc. (NASDAQ:MGNX) Short Interest Down 22.5% in April
MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 2,928,196 shares, a decline of 22.5% from the March 31st total of 3,778,755 shares. Currently, 5.3% of the shares...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.